SPP1 and breast cancer: Therefore, women, who encounter one premalignant lesion with high Osteopontin-c and Osteopontin exon 4, will likely express these molecules in future breast lesions (located in either breast), thus rendering those growths high-risk for full transformation to breast cancer.